Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease Patients

This study is comparing two types of intravenous iron treatment — ferric carboxymaltose and iron sucrose — to see which is more effective and better tolerated in people with chronic kidney disease who have iron deficiency anemia and are not yet on dialysis. **You may be eligible if...** - You are an outpatient aged 18–85 - You have chronic kidney disease with a kidney filtration rate below 60 mL/min and are not on dialysis - You have iron deficiency anemia **You may NOT be eligible if...** - You are on maintenance dialysis - You have a vitamin B12 or folate deficiency - You are receiving erythropoiesis-stimulating agents (ESA) - You have received iron therapy in the past 2 weeks or blood transfusions in the past 3 months - You are pregnant - You have active bleeding from the upper digestive tract, a blood disorder, active cancer, or chronic inflammatory conditions like tuberculosis or ulcerative colitis Talk to your doctor to see if this trial is right for you.